Jan. 16, 2015, 12:38 PM
Aug. 7, 2014, 1:33 PM
- Bioheart (OTCQB:BHRT +6.9%) Q2 results: Revenues: $819.6K (+999%); Net Income (6 mo.): $226.0K (+117.8%); Cash Burn (6 mo.): ($507.0K) (+53.7%).
- No guidance given.
Jul. 11, 2014, 6:32 PM
- As part its restructuring to improve its chances of securing additional financing, Bioheart (BHRT -6.7%) settles a debt of $1,508,219.19 by issuing 37,705,478 shares of common stock. The transaction represents a 7.6% dilution for current shareholders.
- The current holders of the company's Series A Convertible Preferred Stock have agreed to exchange their shares for shares of common stock contingent upon the company securing financing.
Dec. 23, 2008, 3:55 PM
Founded in 1999, Bioheart, Inc. is committed to the development of effective cell technologies to treat cardiovascular diseases. Unlike other organs, the human heart does not have the ability to repair itself once it is damaged. Bioheart's discoveries include multiple cell therapies in various... More
Country: United States
Other News & PR